Tirzep 12.5 mg/0.5 ml (Tirzepatide INN)

Tirzep 12.5 mg Injection (Tirzepatide) is a once-weekly injectable medicine used to improve glycemic control in adults with type 2 diabetes mellitus. It works alongside a healthy diet and regular physical activity to help maintain stable blood glucose levels. Tirzepatide activates both GIP and GLP-1 receptors, which support insulin release, reduce glucagon secretion, and slow gastric emptying. In addition to improving blood sugar management, it may contribute to sustained weight reduction in overweight or obese adults when prescribed by a healthcare professional. Regular use can help optimize metabolic health and reduce the risk of complications associated with uncontrolled diabetes.

Each prefilled syringe of Tirzep 12.5 mg Injection contains:

• Active Ingredient: Tirzepatide 12.5 mg
• Dosage Form: Sterile solution for subcutaneous injection
• Route of Administration: Subcutaneous use only
• Pharmacological Class: Dual Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist

The formulation is designed for once-weekly administration and is intended to provide prolonged therapeutic activity for blood glucose control and metabolic management.